Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Harlan A. Pinto, MD
Stanford University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pretoria Academic Hospital
Pretoria, South Africa
- Veterans Affairs Medical Center - Palo Alto
Palo Alto, California, United States
- Stanford University Medical Center
Stanford, California, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Veterans Affairs Medical Center - Atlanta (decatur)
Decatur, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, Illinois, United States
- Veterans Affairs Medical Center - Chicago (lakeside)
Chicago, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Ccop - Cedar Rapids Oncology Project
Cedar Rapids, Iowa, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Ccop - Duluth
Duluth, Minnesota, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Ccop - Metro-Minnesota
Saint Louis Park, Minnesota, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Veterans Affairs Medical Center - East Orange
East Orange, New Jersey, United States
- Ccop - Northern New Jersey
Hackensack, New Jersey, United States
- University of Rochester Cancer Center
Rochester, New York, United States
- Albert Einstein Comprehensive Cancer Center
The Bronx, New York, United States
- Ireland Cancer Center
Cleveland, Ohio, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Hahnemann University Hospital
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania, United States
- Vanderbilt Cancer Center
Nashville, Tennessee, United States
- Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, United States
- University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin, United States
- Veterans Affairs Medical Center - Madison
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 May 1995
- Primary completion
- 31 May 2002
- Completion
- —
- Last update posted
- 15 Jun 2023
- Registered enrollment
- 32
- Registry id
- NCT00002632
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.